Ernesto Maddaloni

Pubblicazioni

Titolo Pubblicato in Anno
Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment. A Pilot Study JOURNAL OF CLINICAL MEDICINE 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA FRONTIERS IN ENDOCRINOLOGY 2022
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis CIRCULATION RESEARCH 2022
Adult-onset autoimmune diabetes NATURE REVIEWS. DISEASE PRIMERS 2022
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study DIABETIC MEDICINE 2021
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome INTERNAL AND EMERGENCY MEDICINE 2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism ENDOCRINE 2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study DIABETES, OBESITY AND METABOLISM 2021
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease FRONTIERS IN PHARMACOLOGY 2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis INTERNAL AND EMERGENCY MEDICINE 2021
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2021
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity ENDOCRINE 2021
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 2021
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study JOURNAL OF DIABETES RESEARCH 2021
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk DIABETOLOGIA 2021

Progetti di Ricerca

Gruppi di ricerca

Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma